Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-038899
Filing Date
2020-03-26
Accepted
2020-03-26 17:15:19
Documents
2
Period of Report
2019-07-12
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2013474d1_8ka.htm 8-K/A 20012
2 EXHIBIT 99.2 tm2013474d1_ex99-2.htm EX-99.2 573869
  Complete submission text file 0001104659-20-038899.txt   595204
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-35963 | Film No.: 20746957
SIC: 2834 Pharmaceutical Preparations